SHORT-TERM RESULTS OF CARDIOSYNCHRONIZED CONSEQUENTIAL ANTEGRADE PNEUMOCOMPRESSION IN PATIENTS WITH MULTIFOCAL ATHEROSCLEROSIS

Aim. To evaluate the efficacy of CCAPC in complex treatment of the patients with multifocal atherosclerosis and involvement of the heart and lower extremities arteries.

Material and methods. Totally 74 patients included (66 men and 8 women), mean age 63,2±9,3 y.: 32 (43%) with IIa stage and 42 (57%) with IIb stage of lower extremities ischemia; 58 (80%) with II functional class of angina and 16 (20%) with III functional class (by CCS). CCAPC was performed on a “CARDIOPULSAR” software-hardware complex. The protocol of the study consisted in 30 procedures by 60 min. per day. Efficacy of CCAPC was assessed by the changes in EchoCG, 6-minute walking test, DPW, ABI, LDF, activity index DASI, Edinburgh questionnaire of intermittent claudication.

Results. The regression of clinical symptoms was found in all patients after the treatment by CCAPC in cardiosynchronized angioregimen: the significant increase of exercise tolerance was found as DPW, ABI, DASI values, microcirculation parameters by LDF. The assessment of EchoCG parameters (EDS, ESS, EDV, ESV, LVEF) and functional class of angina revealed that after the course of CCAPC coronary blood flow did not change significantly. All patients had a subjective improvement: physical activities increased, dyscomfort in lower extremities decreased as the feelings of chills and cold.

Conclusion. CCAPC is a novel important non-invasive effective and safe method of multifocal atherosclerosis treatment involving the heart and lower extremities vessels.

1. ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline) 2011 http://circ.ahajournals.org/ content/124/18/2020.

2. Alberts MJ, Bhatt DL, Mas JL, et al. Reduction of Atherothrombosis for Continued Health Registry Investigators. Three-year followup and event rates in the international Reduction of Atherothrombosis for Continued Health Registry. Eur Heart J 2009; 30: 2318-26.

3. The external enhanced counterpulsation. Collection of articles, volume 1, volume 2. (Ed. Belenkov JuN). Medicinskaja kompanija “Alimpeks”, 2003, p.123. Russian (Усиленная наружная контрпульсация. Сборник статей, том 1, том 2. (под редакцией Беленкова Ю. Н.). Медицинская компания “Алимпекс”, 2003, c.123).

4. Ermolenko ML, Bayramukova MH, Nikonov SF, et al. Method of an external counterpulsation in treatment of patients with stable coronary artery disease: Methodical recommendations. M.: NCSSH im.A.N.Bakuleva RAMN, 2005, p. 24. Russian (Ермоленко М. Л., Байрамукова М. Х., Никонов С . Ф . и др. Метод наружной контрпульсации в лечении больных ишемичсекой болезнью сердца: Методические рекомендации. М.: НЦССХ им.А.Н.Бакулева РАМН, 2005, c. 24).

5. Sudarev AM. Treatment of peripheral artery disease. Angiology and vascular surgery, M., Izd. “Angiologija info”, 2013; 19, 1: 26-32. Russian (Сударев А. М. Лечение облитерирующих заболеваний артерий нижних конечностей. Ангиология и сосудистая хирургия, М., Изд. “Ангиология инфо”, 2013; 19, 1: 26-32).

6. Hubutiya Ash, Sudarev AM, Tolpekin VE, et al. Domestic system of the external enhanced counterpulsation: development and first experience of clinical application. Cardiology, 2012; 3: 91-4. Russian (Хубутия А. Ш., Сударев А. М., Толпекин В. Е., и др. Отечественная система усиленной наружной контрпульсации: разработка и первый опыт клинического применения. Кардиология, 2012; 3: 91-4).

7. Atkov OYu, Zudin AM, Sudarev AM, et al. Cardiosynchronized pneumocompression in treatment of patients by multifocal atherosclerosis: Educational and methodical recommendations. M.: Izdatel’stvo RUDN, 2014. p. 25. Russian (Атьков О. Ю., Зудин А. М., Сударев А. М. и др.) Кардиосинхронизированная пневмокомпрессия в лечении больных мультифокальным атеросклерозом: Учебно-методические рекомендации. — М.: Издательство РУДН, 2014. c. 25).

8. Arora RR, Chou TM, Jain D, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): Effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coil CW 1999:33:1833-40.

9. Barsness G, Feldman AM, Holmes DRJr, et al. The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results. Clin Cardiol 2001; 24: 435-42.

10. Feldman A, Silver M, Francis G, et al. Treating heart failure with enhanced external counterpulsation (EECP): design of the Prospective Evaluation of EECP in Heart Failure (PEECH) trial. J Card Fail. 2005; 11: 240-5.

11. Lipnitsky EM, Amosov GG, Morozov KM, et al. Application of a rhythmic pneumocompression for treatment of patients with chronic peripheral artery disease. Chest and card. surgery, 2007; 13, 3: 22-6. Russian (Липницкий Е. М., Амосов Г . Г ., Морозов К . М. и др. Применение ритмической пневмокомпрессии для лечении больных с хроническими облитерирующими заболеваниями артерий нижних конечностей. Грудная и серд.сос. хирургия, 2007; 13, 3: 22-6).

12. Delis KT, Knaggs AL. Duration and amplitude decay of acute arterial leg inflow enhancement with intermittent pneumatic leg compression: an insight into the implicated physiologic mechanisms. J Vasc Surg 2005; 42(4): 717-25.

13. Kavros SJ, Dekis KT, Turner NS, et al. Improving Limb Salvage in Critical Limb Ischemia with Intermittent Pneumatic Compression: A Controlled study with 18-month follow-up. J Vasc Surg 2008; 47: 543-9.

14. De Haro, et al. A prospective randomized controlled study with intermittent mechanical compression of the calf in patients with claudication. Journal of Vascular and Endovascular Surgery 2010; 51, 4: 857-62.

15. Breu FX, Zelikovski A, Loberman Z, et al. Efficacy and safety of a new pneumatic compression device for peripheral arterial disease with intermittent claudication. A prospective, randomized, multi-center clinical trial Phlebologie 2014; 43, 1: 5-11.